UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inappropriate prescribing: a systematic overview of published assessment tools

European journal of clinical pharmacology, 2014-01, Vol.70 (1), p.1-11

2014

Volltextzugriff (PDF)

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D64 Variants: A Case Report

International journal of molecular sciences, 2021-06, Vol.22 (12), p.6480

2021

Volltextzugriff (PDF)

Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction

Frontiers in psychiatry, 2024-04, Vol.15, p.1397876

2024

Volltextzugriff (PDF)

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial

Trials, 2021-12, Vol.22 (1), p.919-919, Article 919

2021

Volltextzugriff (PDF)

Pharmaceutical Discharge Management: Implementation in Swiss Hospitals Compared to International Guidelines

Pharmacy, 2021-02, Vol.9 (1), p.33

2021

Volltextzugriff (PDF)

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report

Life (Basel, Switzerland), 2021-07, Vol.11 (7), p.673

2021

Volltextzugriff (PDF)

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting

Pharmacy, 2022-07, Vol.10 (4), p.86

2022

Volltextzugriff (PDF)

Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017?

Pharmacy, 2020-02, Vol.8 (1), p.19

2020

Volltextzugriff (PDF)

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept

Pharmacy, 2021-09, Vol.9 (3), p.152

2021

Volltextzugriff (PDF)

Dispensing of Prescribed Medicines in Swiss Community Pharmacies-Observed Counselling Activities

Pharmacy, 2018-12, Vol.7 (1), p.1

2018

Volltextzugriff (PDF)

A Clinical Practice Perspective on the Evaluation of OATP1B1‐associated Drug Interactions

Clinical pharmacology and therapeutics, 2024-07, Vol.116 (1), p.30-33

2024

Volltextzugriff (PDF)

Determination of risk factors for drug-related problems: a multidisciplinary triangulation process

BMJ open, 2015-01, Vol.5 (3), p.e006376-e006376

2015

Volltextzugriff (PDF)

Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice

Genes, 2024-07, Vol.15 (7), p.862

2024

Volltextzugriff (PDF)

The impact of pharmacist-led medication reconciliation and interprofessional ward rounds on drug-related problems at hospital discharge

International journal of clinical pharmacy, 2023-02, Vol.45 (1), p.117-125

2023

Volltextzugriff (PDF)

Outcomes of early switching from intravenous to oral antibiotics on medical wards

Journal of antimicrobial chemotherapy, 2009-07, Vol.64 (1), p.188-199

2009

Volltextzugriff (PDF)

Translation and validation of a tool to assess the impact of clinical pharmacists’ interventions

International journal of clinical pharmacy, 2019-02, Vol.41 (1), p.56-64

2019

Volltextzugriff (PDF)

Pharmaceutical interventions on prescribed medicines in community pharmacies: focus on patient-reported problems

International journal of clinical pharmacy, 2018-04, Vol.40 (2), p.335-340

2018

Volltextzugriff (PDF)

Nonresponse to high-dose bupropion for depression in a patient carrying CYP2B66 and CYP2C1917 variants: a case report

Pharmacogenomics, 2020-11, Vol.21 (16), p.1145-1150

2020

Volltextzugriff (PDF)

Documentation of pharmaceutical care: development of an intervention oriented classification system

International journal of clinical pharmacy, 2017-04, Vol.39 (2), p.354-363

2017

Volltextzugriff (PDF)

Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems

BMJ open, 2018-03, Vol.8 (3), p.e016610-e016610

2018

Volltextzugriff (PDF)

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene

Frontiers in psychiatry, 2022-07, Vol.13

2022

Volltextzugriff (PDF)

Documentation of pharmaceutical care: Validation of an intervention oriented classification system

Journal of evaluation in clinical practice, 2017-12, Vol.23 (6), p.1425-1432

2017

Volltextzugriff (PDF)

Contribution of Patient Interviews as Part of a Comprehensive Approach to the Identification of Drug-Related Problems on Geriatric Wards

Drugs & aging, 2018-07, Vol.35 (7), p.665-675

2018

Volltextzugriff (PDF)

Demonstrating the clinical pharmacist’s activity: validation of an intervention oriented classification system

International journal of clinical pharmacy, 2015-12, Vol.37 (6), p.1162-1171

2015

Volltextzugriff (PDF)

Assessing the ability of the Drug-Associated Risk Tool (DART) questionnaire to stratify hospitalised older patients according to their risk of drug-related problems: a cross-sectional validation study

BMJ open, 2018-06, Vol.8 (6), p.e021284

2018

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(44)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inappropriate prescribing: a systematic overview of published assessment tools

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D64 Variants: A Case Report

Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial

Pharmaceutical Discharge Management: Implementation in Swiss Hospitals Compared to International Guidelines

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting

Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017?

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept

Dispensing of Prescribed Medicines in Swiss Community Pharmacies-Observed Counselling Activities

A Clinical Practice Perspective on the Evaluation of OATP1B1‐associated Drug Interactions

Determination of risk factors for drug-related problems: a multidisciplinary triangulation process

Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice

The impact of pharmacist-led medication reconciliation and interprofessional ward rounds on drug-related problems at hospital discharge

Outcomes of early switching from intravenous to oral antibiotics on medical wards

Translation and validation of a tool to assess the impact of clinical pharmacists’ interventions

Pharmaceutical interventions on prescribed medicines in community pharmacies: focus on patient-reported problems

Nonresponse to high-dose bupropion for depression in a patient carrying CYP2B66 and CYP2C1917 variants: a case report

Documentation of pharmaceutical care: development of an intervention oriented classification system

Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene

Documentation of pharmaceutical care: Validation of an intervention oriented classification system

Contribution of Patient Interviews as Part of a Comprehensive Approach to the Identification of Drug-Related Problems on Geriatric Wards

Demonstrating the clinical pharmacist’s activity: validation of an intervention oriented classification system

Assessing the ability of the Drug-Associated Risk Tool (DART) questionnaire to stratify hospitalised older patients according to their risk of drug-related problems: a cross-sectional validation study

Suchergebnisse filtern